All News

Researchers showed that patients with nonsymptomatic, advanced follicular lymphoma (FL) benefit from Rituxan (rituximab) over watchful waiting.

A phase 2 trial presented at the American Society of Hematology in December could pave the way for a second approval for Istodax (romidepsin).

Study shows experimental drug ponatinib acts against a mutation found in small percentage of chronic myeloid leukemia cases that is resistant to other forms of therapy

Treatment differs for Acute myeloid leukemia pediatric patients compared with older adults.

Chronic myeloid leukemia (CML)usually can be managed as a chronic disease by therapies, including Gleevec (imatinib) or two newer drugs, Sprycel (dasatinib) or Tasigna (nilotinib).

For Hodgkin lymphoma patients who progress after a stem cell transplant, two new treatments may bring new hope.